Seelos Therapeutics, Inc. (SEELQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
May 6, 2025, 4:00 PM EDT
Seelos Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Cash & Equivalents | 3 | 15.53 | 78.73 | 15.66 | 10.26 | Upgrade
|
| Cash & Short-Term Investments | 3 | 15.53 | 78.73 | 15.66 | 10.26 | Upgrade
|
| Cash Growth | -80.71% | -80.27% | 402.71% | 52.64% | 24330.95% | Upgrade
|
| Receivables | 0.76 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 1.57 | 6.94 | 4.54 | 1.79 | 0.84 | Upgrade
|
| Other Current Assets | 0.08 | 0.2 | 0.19 | 0.04 | - | Upgrade
|
| Total Current Assets | 5.4 | 22.67 | 83.46 | 17.49 | 11.1 | Upgrade
|
| Property, Plant & Equipment | 0.02 | 0.07 | 0.04 | - | - | Upgrade
|
| Total Assets | 5.42 | 22.75 | 83.5 | 17.49 | 11.1 | Upgrade
|
| Accounts Payable | 16.4 | 3.63 | 1.69 | 1.89 | 0.8 | Upgrade
|
| Accrued Expenses | 2.52 | 7.28 | 3.73 | 1.92 | 1.92 | Upgrade
|
| Current Portion of Long-Term Debt | 14.21 | 11.87 | 1.03 | 2.43 | - | Upgrade
|
| Current Portion of Leases | 0.02 | 0.06 | 0.04 | - | - | Upgrade
|
| Other Current Liabilities | 5.78 | 2.33 | 1.8 | 1.19 | 8.06 | Upgrade
|
| Total Current Liabilities | 38.93 | 25.16 | 8.29 | 7.43 | 10.78 | Upgrade
|
| Long-Term Debt | - | 8.18 | 17.89 | 7.29 | - | Upgrade
|
| Long-Term Leases | - | 0.02 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 0.2 | 0.33 | Upgrade
|
| Total Liabilities | 38.93 | 33.36 | 26.18 | 14.92 | 11.1 | Upgrade
|
| Common Stock | 0.01 | 0 | 0.11 | 0.05 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 219.11 | 204.13 | 198.43 | 77.68 | 56.03 | Upgrade
|
| Retained Earnings | -252.63 | -214.74 | -141.21 | -75.16 | -56.06 | Upgrade
|
| Shareholders' Equity | -33.51 | -10.61 | 57.32 | 2.57 | -0.01 | Upgrade
|
| Total Liabilities & Equity | 5.42 | 22.75 | 83.5 | 17.49 | 11.1 | Upgrade
|
| Total Debt | 14.23 | 20.12 | 18.96 | 9.72 | - | Upgrade
|
| Net Cash (Debt) | -11.23 | -4.59 | 59.78 | 5.94 | 10.26 | Upgrade
|
| Net Cash Growth | - | - | 906.67% | -42.13% | - | Upgrade
|
| Net Cash Per Share | -293.39 | -165.66 | 2525.50 | 509.35 | - | Upgrade
|
| Filing Date Shares Outstanding | 0.11 | 0.03 | 0.03 | 0.02 | 0.01 | Upgrade
|
| Total Common Shares Outstanding | 0.08 | 0.03 | 0.03 | 0.01 | 0.01 | Upgrade
|
| Working Capital | -33.53 | -2.48 | 75.17 | 10.07 | 0.32 | Upgrade
|
| Book Value Per Share | -437.92 | -380.21 | 2086.45 | 181.10 | -0.99 | Upgrade
|
| Tangible Book Value | -33.51 | -10.61 | 57.32 | 2.57 | -0.01 | Upgrade
|
| Tangible Book Value Per Share | -437.92 | -380.21 | 2086.45 | 181.10 | -0.99 | Upgrade
|
Updated Aug 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.